Dexilant 30 mg, Kapseln mit veränderter Wirkstofffreisetzung
7680629930020
CH-62993
Kapseln mit veränderter Wirkstofffreisetzung
Associated product:
DEXILANT caps ret 30 mg 28 pce
1 / 3
google
Article details
- Package size
- 28
- Selling units
- 28
- Measure
- Kapsel(n)
- Galenic form
- Kapseln mit veränderter Wirkstofffreisetzung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
sacchari sphaerae
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
magnesii subcarbonas ponderosus
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum substitutum humile
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum
|
- | Substance | HNIDK |
|
acidi methacrylici et methylis methacrylatis polymerisatum 1:2
|
- | Substance | HNIDK |
|
acidi methacrylici et methylis methacrylatis polymerisatum 1:1
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
macrogolum 8000
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
triethylis citras
|
- | Substance | HNIDK |
|
carrageenanum
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
kalii chloridum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
aqua purificata
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 132
|
- | Substance | FIMDK |
|
cera carnauba
|
- | Substance | HNIDK |
|
lacca
|
- | Substance | HNIDK |
|
glyceroli mono-oleas
|
- | Substance | HNIDK |
|
natrium
|
0.01 MG | Substance | HBESI |
|
saccharum
|
68.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 39.90
Specialties list
Yes
Generic
No
SL addition date:
01/07/2014
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 62993
- Drug name
- Dexilant, Kapseln mit veränderter Wirkstofffreisetzung
- Galenic form
- RETH
- ATC Code
- A02BC06
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 09/05/2014
- Authorization expiration date
- 31/12/9999
- IT Number
- 04.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- DEXILANT caps ret 30 mg 28 pce
- Description (DE)
- DEXILANT Ret Kaps 30 mg 28 Stk
- Market launch
- 09/05/2014
- Narcotic (BTM)
- No
Other package sizes (5)
DEXILANT caps ret 30 mg 14 pce
14 KAP
GTIN: 7680629930013
DEXILANT caps ret 30 mg 98 pce
98 KAP
GTIN: 7680629930051
DEXILANT caps ret 60 mg 14 pce
14 KAP
GTIN: 7680629930037
DEXILANT caps ret 60 mg 28 pce
28 KAP
GTIN: 7680629930044
DEXILANT caps ret 60 mg 56 pce
56 KAP
GTIN: 7680629930068